According to the American Heart Association/American Stroke Association (AHA/ASA), stroke is the number five cause of death and a leading cause of adult disability in the United States. Swedish is committed to increasing the quality of care and outcomes for stroke patients. Recently, Swedish Cherry Hill and Swedish Edmonds were recognized by the AHA/ASA’s Get With The Guidelines®-Stroke Quality Achievement Awards.
'news' Swedish News Blog posts
Swedish Cherry Hill and Swedish Edmonds Recognized with the 2015 Get with the Guidelines-Stroke Quality Achievement Award
Major updates to the Ivy Glioblastoma Atlas Project provide researchers with valuable tools to find cures for aggressive brain cancers
SEATTLE, WASH. — May 14, 2015 —Robust new data added to the Ivy Glioblastoma Atlas Project (Ivy GAP) changes the scope and impact of this publicly available resource for researchers and clinicians searching for treatments for this most deadly and aggressive of brain cancers, glioblastoma multiforme.
Learn about advancements in breast cancer care at the Many Faces of Breast Cancer event at Swedish Issaquah on May 7 from 5:30-8 p.m.
The Swedish Cancer Institute at Issaquah is hosting a free educational talk about advancements in breast cancer care on Thursday, May 7 from 5:30-8 p.m. Learn about genetic counseling, the latest screening and treatment options, and get details about the comprehensive breast cancer services and survivorship support offered by Swedish.
Swedish’s Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment launches new clinical trial to treat brain cancer with the Nativis Voyager Radio Frequency Energy (RFE) Medical Device
The Swedish Neuroscience Institute’s Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment today announced a new clinical trial for treating brain cancer. The trial (ID no. NCT02296580 – “A Feasibility Study of the Nativis Voyager System in Patients with Recurrent Glioblastoma Multiforme”), sponsored by Nativis, Inc. in Seattle – will investigate the safety and efficacy of the Nativis Voyager RFE medical device in humans. The device has shown promise in preclinical studies.
SEATTLE, April 24, 2015 — Swedish Ballard will open a new Level II Nursery on Monday, April 27. The Level II Nursery allows for premature babies— born as early as 34 weeks gestational age — to receive specialized, around-the-clock care from a trained team of experts.